MENU
+Compare
FHLC
ETF ticker: NYSE ARCA
AS OF
Jun 4, 04:59 PM (EDT)
Price
$63.28
Change
+$0.17 (+0.27%)
Net Assets
2.43B

FHLC stock forecast, quote, news & analysis

The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care 25/50 Index... Show more

Category: #Health
FHLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for FHLC with price predictions
Jun 04, 2025

FHLC in upward trend: price may ascend as a result of having broken its lower Bollinger Band on May 14, 2025

FHLC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 48 cases where FHLC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for FHLC just turned positive on May 28, 2025. Looking at past instances where FHLC's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FHLC advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on June 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on FHLC as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FHLC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV).

Industry description

The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care 25/50 Index. The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care 25/50 Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care 25/50 Index. The fund is non-diversified.

Market Cap

The average market capitalization across the Fidelity MSCI Health Care ETF ETF is 17.24B. The market cap for tickers in the group ranges from 101.9M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is PLRX at 101.9M.

High and low price notable news

The average weekly price growth across all stocks in the Fidelity MSCI Health Care ETF ETF was 2%. For the same ETF, the average monthly price growth was -3%, and the average quarterly price growth was -7%. VERA experienced the highest price growth at 70%, while NTLA experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Fidelity MSCI Health Care ETF ETF was 42%. For the same stocks of the ETF, the average monthly volume growth was -6% and the average quarterly volume growth was 43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 71
Price Growth Rating: 61
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: 25 (-100 ... +100)
View a ticker or compare two or three
FHLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
82 Devonshire StreetBoston
Phone
N/A
Web
www.institutional.fidelity.com